Tyrosine kinase inhibitors in Kosaki/Penttinen syndromes: new reports, follow-up of treated individuals and literature review

Céline Jost(Maison des Sciences sociales et des Humanités de Dijon), Laurence Faivre(Inserm), Cecilie F. Rustad(University of Oslo), Nikolas Herold(Karolinska University Hospital), Helena Iznardo(Hospital de Sant Pau), Olav Aga Kildal(Telemark Hospital), Andrea Gazzin(University of Turin), Agnès Maurer(Inserm), José M. Mascaró(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), A Cassisa(Candiolo Cancer Institute), Daniela Cantarella(Candiolo Cancer Institute), Eulàlia Baselga(Hospital Sant Joan de Déu Barcelona), Thirona Naicker, Silvia Kalantari(University of Pavia), Maxime Luu(Inserm), Enzo Médico(Candiolo Cancer Institute), Diana Carli(University of Turin), Alessandro Mussa(Unknown), Ann Nordgren(Karolinska University Hospital), Marc Bardou(Université de Bourgogne), Claudio Isella(Candiolo Cancer Institute), Titas Gladkauskas(University of Bergen), Théo Gaumet(Inserm), Yordi-Michaël Bouhatous(Inserm), Ashmika Gokhul, Liubinka Mirakovska(Inserm), Elise Schaefer(Hôpitaux Universitaires de Strasbourg), Dinel Pond(Children’s Minnesota - St. Paul Hospital), Antoinette Chateau(University of KwaZulu-Natal), Ingrid Voktor Svinvik(Oslo University Hospital), Tara Wenger(University of Washington Medical Center), Jean‐Baptiste Demoulin(de Duve Institute), Jean-Emmanuel Kurtz(Institut de Cancérologie Strasbourg), Cecilie Bredrup(Haukeland University Hospital)
European Journal of Human Genetics
July 8, 2026
Cited by 0


Related Papers